Cargando…
Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning
Background: Early prediction of symptoms and mortality risks for COVID-19 patients would improve healthcare outcomes, allow for the appropriate distribution of healthcare resources, reduce healthcare costs, aid in vaccine prioritization and self-isolation strategies, and thus reduce the prevalence o...
Autores principales: | Jamshidi, Elham, Asgary, Amirhossein, Tavakoli, Nader, Zali, Alireza, Dastan, Farzaneh, Daaee, Amir, Badakhshan, Mohammadtaghi, Esmaily, Hadi, Jamaldini, Seyed Hamid, Safari, Saeid, Bastanhagh, Ehsan, Maher, Ali, Babajani, Amirhesam, Mehrazi, Maryam, Sendani Kashi, Mohammad Ali, Jamshidi, Masoud, Sendani, Mohammad Hassan, Rahi, Sahand Jamal, Mansouri, Nahal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262614/ https://www.ncbi.nlm.nih.gov/pubmed/34250465 http://dx.doi.org/10.3389/frai.2021.673527 |
Ejemplares similares
-
Using Machine Learning to Predict Mortality for COVID-19 Patients on Day 0 in the ICU
por: Jamshidi, Elham, et al.
Publicado: (2022) -
Personalized predictions of adverse side effects of the COVID-19 vaccines
por: Jamshidi, Elham, et al.
Publicado: (2022) -
Longevity of immunity following COVID-19 vaccination: a comprehensive review of the currently approved vaccines
por: Jamshidi, Elham, et al.
Publicado: (2022) -
Anti-cancer effects of human placenta-derived amniotic epithelial stem cells loaded with paclitaxel on cancer cells
por: Babajani, Amirhesam, et al.
Publicado: (2022) -
Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer
por: Babajani, Amirhesam, et al.
Publicado: (2020)